1Alfredo Garzino-Demo,Anthony L. Devico,Robert C. Gallo. Chemokine Receptors and Chemokines in HIV Infection[J] 1998,Journal of Clinical Immunology(4):243～255
同被引文献38
1Cooley LA, Lewin SR . HIV-1 cell entry and advances in viral entry inhibitor therapy[J] . J Clin Virol , 2003, (26): 121.
2Goto T, Nakai M, Ikuta K. The life-cycle of human immunodeficiecy virus type 1[J]. Micron,1998,29(2/3):123.
3Jacobson JM, Lowy I, Fletcher CV, et al. Single-dose safety,phacmacology, and antiviral activity of the human immunodeficiecy virus (HIV) type 1 entry inhibitor PRO542 in HIV-infected adults[J]. J Infect Dis ,2000,182(1) :326.
4Shearer WT, Israel RT, Starr S, et al. Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2study[J]. J Infect Dis ,2000,182(6): 1774.
5Esser M, Mori T, Mondor I, et al. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding,fusion,and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120[J]. J Virol ,1999 , 73 : 4360 .
6Wyatt R, Kwong P, Desjardins E, et al. The antigenic structure of the HIV gp120 envelope glucoprotein[J]. Nature, 1998,393:705.
7Hoshino H. Coreceptors of H1V infection and the development of HIV entry inhibitors: overview and targets[J]. Jpn J Clin Med, 2002,60(1):81.
8Berson J F, Doms R W. Structure-function studies of the HIV-1 coreceptors[J]. Semin Immunol , 1998,10:237.
9Bleul C, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTER/fusin and blocks HIV-1 entry[J]. Nature, 1996,382: 829.
10Deng H, Liu RH, Ellmeier W, et al. Identification of a majorco-receptor for primary isolates of HIV-1[J]. Nature, 1996,381:661.
